Cellectis (CLLS) Research & Development (2015 - 2026)

Cellectis' Research & Development history runs 12 years deep, the most recent figure standing at -$27.2 million for Q1 2026.

• In Q1 2026, Research & Development fell 23.96% year-over-year to -$27.2 million; the TTM figure through Mar 2026 stood at -$98.8 million (down 208.63% YoY), while the FY2025 annual figure was -$93.5 million, down 203.29% from the prior year.
• Research & Development for Q1 2026 stood at -$27.2 million, down from -$24.4 million in the prior quarter.
• The five-year high for Research & Development was $160.2 million in Q4 2024, with the low at -$27.2 million in Q1 2026.
• The 5-year median for Research & Development is -$23.1 million (2025), against an average of -$2.4 million.
• The sharpest annual moves came in 2023 and 2025: Research & Development surged 801.42% in 2023, then sank 115.25% in 2025.
• Cellectis' Research & Development stood at -$21.4 million in 2022, then soared by 801.42% to $150.3 million in 2023, then climbed by 6.57% to $160.2 million in 2024, then tumbled by 115.25% to -$24.4 million in 2025, then dropped by 11.26% to -$27.2 million in 2026.
• Business Quant data shows CLLS's Research & Development at -$27.2 million in Q1 2026, -$24.4 million in Q4 2025, and -$24.1 million in Q3 2025.